0      0


AM21-85: A New Look at Two Familiar Topics: Platelet Transfusion Support for Immune Refractory Patients and the ABO COVID-19 Connection (AABB-ASHI Joint Symposium)


‐ Oct 19, 2021 9:00pm

Expiration Date: Dec 31, 2023


Credits: None available.

In this session, our first presenter will discuss an unique algorithm for selecting compatible platelets for alloimmune refractory patients. The second presenter will review recent research on ABO antibodies and the differential susceptibility of ABO blood groups to COVID-19.

To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.

Learning Objectives:

  • Describe the current findings regarding ABO and susceptibility to COVID-19 infection.
  • Discuss how knowledge of the complexity of ABO antigens and antibodies may help explain differential susceptibility to COVID 19
  • Compare the platelet donor selection method described in the presentation with the “HLA matching” method for selecting platelet donors for immune refractory patients

Moderator(s):

Speaker(s):

Disclosures

  • Manish Gandhi, MD:
    Nothing to Disclose
  • Carol Pancoska, PhD:
    Nothing to Disclose
  • Lori West, MD, DPhil, FRCPC:
    Nothing to Disclose

Tags:

new innovations new techniques and new technologies immunohematology includes serology patient testing Laboratory Information Systems

All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available


AM21-85: A New Look at Two Familiar Topics: Platelet Transfusion Support for Immune Refractory Patients and the ABO COVID-19 Connection (AABB-ASHI Joint Symposium) Evaluation